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Objective: To examine effects of high omega-3 (n-3) polyunsaturated fatty acid (PUFA) diets on devel-
opment of osteoarthritis (OA) in a spontaneous guinea pig model, and to further characterise patho-
genesis in this model. Modern diets low in n-3 PUFAs have been linked with increases in inﬂammatory
disorders, possibly including OA. However, n-3 is also thought to increases bone density, which is
a possible contributing factor in OA. Therefore we aim to determine the net inﬂuence of n-3 in disease
development.
Method: OA-prone Dunkin-Hartley (DH) Guinea pigs were compared with OA-resistant Bristol Strain-2s
(BS2) each fed a standard or an n-3 diet from 10 to 30 weeks (10/group). We examined cartilage and
subchondral bone pathology by histology, and biochemistry, including collagen cross-links, matrix
metalloproteinases (MMPs), alkaline phosphatase, glycosaminoglycan (GAG), and denatured type II
collagen.
Results: Dietary n-3 reduced disease in OA-prone animals. Most cartilage parameters were modiﬁed by n-
3 diet towards those seen in the non-pathological BS2 strain e signiﬁcantly active MMP-2, lysyl-pyr-
idinoline and total collagen cross-links e the only exception being pro MMP-9 which was lower in the
BS2, yet increased with n-3. GAG content was higher and denatured type II lower in the n-3 group.
Subchondral bone parameters in the DH n-3 group also changed towards those seen in the
non-pathological strain, signiﬁcantly calcium:phosphate ratios and epiphyseal bone density.
Conclusion: Dietary n-3 PUFA reduced OA in the prone strain, and most disease markers were modiﬁed
towards those of the non-OA strain, though not all signiﬁcantly so. Omega-3 did not increase markers of
pathology in either strain.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd.
Open access under the Elsevier OA license.Introduction
In an ageing population, osteoarthritis (OA) is set to become the
fourth leading cause of disability by 20201, so with the current lack of
effective treatments there is anurgentneed for preventativemeasures.
The high omega-6 (n-6) polyunsaturated fatty acid (PUFA)
content in Western diets has been associated with a number of
inﬂammatory disorders such as heart disease, rheumatoid arthritis
and colitis. Similarly, elevated levels of n-6 have been linked to OA
in bone and cartilage2,3. “Western” diets are cited as having an
n-6:n-3 ratio of between 15 and 30:1, whereas diets for which we
are naturally adapted, such as those for Palaeolithic and modern: J.F. Tarlton, Matrix Biology,
gford, Bristol BS40 5DU, UK.
ton).
ernational. Published by Elsevier Lhunter-gatherers, contain roughly equal levels of n-6 and n-3
(1:1e2:1)4. Thus, dietary supplementation with n-3 PUFA has been
recommended to redress this imbalance.
PUFAs are essential fatty acids and precursors to a number of
important factors called eicosanoids, such as prostaglandins,
thromboxanes, leukotrienes and resolvins. These mediate various
processes including inﬂammation and bone metabolism. Conver-
sion of PUFAs to eicosanoids is achieved by the action of
cyclo-oxygenases (COX) and lipoxygenases (LOX). Omega-3 and n-6
generate different series of eicosanoids, those from n-6 are gener-
ally highly pro-inﬂammatory and those from n-3 somewhat less so.
In particular, PGE2, derived from n-6 PUFAs, has been associated
with inhibition of anabolic processes and increased proteolytic
degradation of cartilage5e7. Therefore, manipulation of the
precursors of prostaglandins is likely to have an effect on the
initiation and progression of OA. There is some evidence that n-3
PUFA can be beneﬁcial in humans8 and animals9,10, and in vitrotd. Open access under the Elsevier OA license.
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hand, there is considerable evidence indicating that n-3 PUFAs
promote bone formation and increase bone density13,14. OA is
characterised by increased subchondral bone density, and therefore
n-3 induced bone formation may exacerbate OA progression15e19.
With the potential for both beneﬁcial and detrimental effects, it is
essential that the net inﬂuence of n-3 PUFAs on OA is determined
before being recommended to sufferers and those at risk.
Previous studies have established the use of the Dunkin-Hartley
(DH) guinea pig as a naturally occurring model of OA20e22, with the
Bristol Strain-2 (BS2) as an OA-resistant control17,23. Studies have
also examined bone and cartilage changes in DH guinea pigs
compared with other OA-resistant strains15,24. The speciﬁc aims of
this study are (1) to determine how dietary supplementationwith n-
3 fatty acids inﬂuences the progression of OA in the disease-prone
DH guinea pigs and the OA-resistant BS2; and (2) to further char-
acterise the DH/BS2 spontaneous guinea pig model of human OA.Materials and methods
Animals and diets
We used the established DH guinea pig model of spontaneous
OA (Harlan UK, Oxon, UK), with the BS2 as an OA-resistant control
(ASU, University of Bristol, UK). Animals were given a standard
commercial diet until 10 weeks old, and then 10 animals from each
strainwere randomly allocated to either a deﬁned control feed with
n-6:n-3 ratio of 22:1 (typical of a “Western” diet), or a ‘high n-3’
diet with n-6:n-3 of 1.5:1 (see Table I; Teklad Custom Research
Diets, UK). Each diet had 5% fat contents, contained the anti-oxidant
tert-butylhydroquinone, and was vacuum packed in nitrogen at
20C to minimise oxidation. Animals underwent no intervention
other than dietary modiﬁcation, and were reared with free access
to food and water. After euthanasia (in accordance with UK regu-
lations) at 30 weeks old, the hind legs were removed. All samples
were stored at 80C prior to analysis.Histological disease assessment
The right tibial plateauwas removed, divided coronally through the
insertion point of the collateral ligament, and the full width anteriorTable I
Composition of diets
g/kg Control (high n-6) High n-3
Alfalfa meal 380 380
Wheat 204 204
Oats 146 146
Soybean meal 140 140
Soybean hulls 50 50
Safﬂower oil 18 10
Canola oil 12 8
Corn oil 10 e
Fish oil e 17
Coconut oil, hydrogenated 10 7
Mineral mix 0.5 0.5
Dicalcium phosphate 15 15
Sodium chloride 7 7
Magnesium oxide 1 1
Vitamin mix 5 5
Stay-C35 (35% ascorbic acid) 1 1
DL-Alpha-Tocopheryl acetate (500 IU/g) 0.3 0.3
Choline chloride 1 1
Folic acid 0.004 0.004
Vitamin A palmitate (500,000 U/g) 0.04 0.04
Vitamin D3, cholecalciferol (500,000 U/g) 0.004 0.004
TBHQ (antioxidant) 0.04 0.04
n-6:n-3 22:1 1.5:1section was ﬁxed in neutral buffered formalin, decalciﬁed and pro-
cessed for wax histology using standard procedures. Sections were
stained with toluidine blue or Safranin-O, and scored semi-
quantitatively for OA severity, using a combination of the adapted
Mankin scoring system and the Osteoarthritis Research Society Inter-
national (OARSI) OA histopathology grading system which includes
elements of subchondral bone changes23,25. Three sections were
“blind” scored per animal, and scoreswere summed for each animal to
give an overall histological score, with a possible range of 0e20.
Cartilage biochemistry
Cartilage from the posterior section of each tibial plateau was
removed for analysis. Tissue taken from the left knee was analysed
for glycosaminoglycan (GAG), and denatured and native type II
collagen, whilst matrix metalloproteinase (MMP)-2 and MMP-9
activity and collagen cross-link analysis were undertaken on the
right. All chemicals were purchased from Sigma unless otherwise
stated.
Cartilage extract preparation
Freeze-dried samples were digested with tosyl-L-lysine chlor-
omethyl ketone (TLCK)-treated bovine pancreatic a-Chymotrypsin
(1 mg/ml) in 50 mM Tris buffer pH 7.5 containing inhibitors (1 mM
iodoacetamide, 1 mM EDTA,10 mg/ml pepstatin A). Digestion of dena-
tured collagenwas continued for 18 hat 34C and the reaction stopped
by the addition of tosyl-L-phenylalanine chloromethyl ketone (TPCK).
The samples were centrifuged, supernatants removed and the pellets
(remaining native collagen) digested with Proteinase K (1 mg/ml) in
50 mM Tris buffer pH7.5 at 56C, with TLCK and TPCK. After 18 h,
digestion was stopped by heating samples at 100C for 15 min. Undi-
gested material was removed, freeze-dried and weighed.
Type II collagen
The chymotrypsin and proteinase K extracts were assayed for
type II collagen (% dry weight) and denatured type II (% type II) by
inhibition ELISA using a mouse IgG monoclonal antibody to dena-
tured type II collagen, as previously described26.
GAG
The extracts were assayed for sulphated GAGs (% dry weight) by
a colorimetric assay, using dimethylmethylene blue (DMMB) as
previously reported27.
MMPs
Tissue was freeze-dried, and extracted (0.1% Brij 35 in 20 mM
triethanolamine; 20 ml/mg) at 4C for 18 h. Extracts were assayed
for MMP-2 and MMP-9 activity (% standard MMP-2) by gelatin
zymography as previously described28.
Collagen analyses
Collagen content (% dry weight) was determined by hydrox-
yproline analysis of a tissue hydrolysate using a continuous-ﬂow
autoanalyser (Burkard Scientiﬁc, Uxbridge, UK) as previously
described29,30. Mature [hydroxylysyl-pyridinoline (HL-Pyr) and
lysyl-pyridinoline (L-Pyr)] and immature hydroxyketonorleucine
(HLKNL) collagen cross-links were quantiﬁed (M/M collagen) using
modiﬁed amino acid analysis as described previously31. Lysine
hydroxylation was determined using a modiﬁed amino acid anal-
ysis program as previously described29.
Subchondral bone biochemistry
Subchondral bone was sampled from the posterior medial tibial
plateau after removal of the articular cartilage, by cryosectioning to
Fig. 1. Differences in individual pathology scores for each criteria as a result of diet (Std
vs n-3 in the DH strain) and strain (DH vs BS2 both fed a standard diet). Closed circles,
DH fed a standard diet; open circles, DH fed an n-3 diet; closed triangles, BS2 fed
a standard diet. Total pathology scores for all comparisons are shown in Table II.
Fig. 2. Differences in cartilage composition as a result of Strain (DH vs BS2) or Diet
(standard diet black bars, n-3 diet grey bars, BS2/n-3 unﬁlled grey bars). (A) GAG (DH
std n¼ 9, DH n-3 n¼ 10, BS2 std n¼ 9, BS2 n-3 n¼ 8); (B) Denatured type II collagen
(DH std n¼ 9, DH n-3 n¼ 9, BS2 std n¼ 10, BS2 n-3 n¼ 10). For Diet ##P¼ 0.003.
L. Knott et al. / Osteoarthritis and Cartilage 19 (2011) 1150e11571152a depth of 450 mm, and collecting the sections. Sectioning in this
manner powders the subchondral bone with minimal losses or
contamination. The resulting samples were extracted for soluble
proteins and the extracts assayed for MMP-2 and MMP-9 as
described earlier. In addition extracts were analysed for alkaline
phosphatase (ALP) activity (mU/L) by conversion of p-nitro-
phenylphosphate, to p-nitrophenol and monitored at 405 nm using
a Konelab analyser32.
Collagen quantiﬁcation and cross-link analysis were undertaken
on the insoluble pellet as described earlier. Mineral calcium and
phosphate were quantiﬁed from aliquots of hydrolysate, using
a Konelab analyser, whereby inorganic phosphate forms a complex
with ammonium molybdate, measured at 340 nm33, and calcium
ions with arsenazo III, measured at 660 nm34. These values are used
to give a mineral calcium:phosphate ratio.
Dual-energy X-ray absorptiometry (DXA)
The remaining left proximal tibial epiphysis adjacent to the
subchondral was analysed by DXA using a PIXImis 1.44 (Lunar,
Maddison, WI) ﬁtted with small animal software. The bone mineral
density (BMD, mg/cm2) of an area (7 mm 7 mm) immediately
distal to the growth plate was measured35.
Statistical analysis
Results were analysed using PASW Statistics v17 (SPSS.com).
Data was tested for normality using the KolmogoroveSmirnov test
and for homogeneity of variances using Levene’s test of equality of
variances. Assuming normality and equal variances, a one-way
ANOVA was used to test for signiﬁcant differences speciﬁc for
each aim: (1) model characterisation, BS2 compared to DH for n-6
control diet; (2) OA progression, n-3 compared to n-6 diet for DH
strain; (3) OA promotion, n-3 compared to n-6 diet in control BS2
strain. Where data was not normal and variances not equal, log
transformations were used, otherwise a KruskaleWallis test with
Dunn’s multiple comparison tests. To evaluate multiple outcomes
in the model, binomial discrete probability distribution and Chi-
square tests were performed. Graphical data is presented as
mean S.E.M.
Results
Characterisation of the DH/BS2 model
OA pathology
The pathology scores were signiﬁcantly lower in the BS2 strain
compared to the DH strain (P¼ 0.001), in line with previous studies
verifying the BS2 strain as an OA-resistant guinea pig strain23.
When the separate scores were considered, therewas a strain effect
overall (P< 0.0001), with toluidine blue (P¼ 0.0008), cartilage
structure (P¼ 0.0057) and OARSI criteria (P¼ 0.0007) each being
lower in the BS2 (Fig. 1).
Pathogenic markers
Cartilage. The GAG and type II collagen (total or denatured)
contents of the cartilage were similar between strains [Fig. 2(A and
B)]. However the post-translational modiﬁcations of the collagen
weremarkedly different between OA-prone DH and non-prone BS2
strains, with signiﬁcantly lower levels of lysyl hydroxylation and
higher levels of the cross-link L-Pyr, associated with a mineralising
matrix, in the DH strain [P¼ 0.01 and P< 0.0001 respectively;
Fig. 3(A and B)].
Differences were also notable in mediators of matrix metabo-
lism e the DH strain having signiﬁcantly higher cartilage pro MMP-9 and pro MMP-2 levels than the control BS2 Strain [P¼ 0.012 and
P< 0.0001 respectively, Fig. 3(C and D)], and the levels of pro MMP-
2 were positively correlated with the total histological changes of
the joint surface (r¼ 0.576; P¼ 0.003) and for each individual
parameter and overall (P< 0.05). The BS2s had very low levels of
pro MMP-2, with no detectable active MMP-2 [Fig. 3(E)].
Subchondral bone. The collagen content was signiﬁcantly higher in
the DH animals compared to BS2’s (P¼ 0.04; Table II), and was also
positively correlated with histological score of the cartilage
(r¼ 0.403, P¼ 0.034). Again the levels of lysyl hydroxylation were
low in DH animals on the standard n-6 diet compared to control
BS2s, although this was not signiﬁcant [Fig. 4(A)]. DH subchondral
bone had signiﬁcantly more total cross-links [P¼ 0.006, Fig. 4(B)]
compared to BS2s.
The Ca:P was lower in the DH than the control guinea pig sub-
chondral bone [P¼ 0.002, Fig. 4(C)]. Although we did not directly
measure the BMD of the subchondral bone region, there was
signiﬁcantly greater BMD in the adjacent proximal tibial epiphysis
in the DH (P¼ 0.0001; Table II).
Levels of ALP, a marker of osteoblast activity, were signiﬁcantly
higher in DH bone extracts compared to the BS2 strain [P¼ 0.04;
Fig. 4(D)]. Pro MMP-9 levels were more than 2-fold lower in the DH
animals [P¼ 0.001; Fig. 4(E)] and were negatively correlated with
histological score (r¼0.540, P¼ 0.004). There was no detectable
pro or active MMP-2 in the BS2 extracts, and below accurately
quantiﬁable levels of active MMP-2 in the DH animals only.
Effect of n-3 on disease progression in OA-developing DH strain
OA pathology
The n-3 diet halved the average histological scores in the DH
animals (P¼ 0.048) by comparison with the standard diet. When
Fig. 3. Differences in biochemical parameters of cartilage as a result of Strain (DH vs
BS2) or Diet (standard diet black bars, n-3 diet grey bars, BS2/n-3 unﬁlled grey bars).
(A) Lysyl hydroxylation of collagen (DH std n¼ 9, DH n-3 n¼ 8, BS2 std n¼ 9, BS2 n-3
n¼ 9); (B) Lysyl-pyridinoline (DH std n¼ 9, DH n-3 n¼ 8, BS2 std n¼ 8, BS2 n-3 n¼ 7):
(C) Pro MMP-9 (DH std n¼ 9, DH n-3 n¼ 10, BS2 std n¼ 10, BS2 n-3 n¼ 10); (D) Pro
MMP-2 (DH std n¼ 9, DH n-3 n¼ 10, BS2 std n¼ 10, BS2 n-3 n¼ 10); (E) MMP-2
activation (DH std n¼ 9, DH n-3 n¼ 10, BS2 std n¼ 10, BS2 n-3 n¼ 10). For diet
#P< 0.05, ##P< 0.01. For strain **P< 0.01, ***P< 0.001.
Table II
Summary of results
DH
Standard diet n-3 diet
Total path. Scorey 8.97 (6.17, 11.8) 4.56 (0.83, 8.2
Cartilage
Type II collageny 55.7 (47.9, 63.4) 58.7 (50.7, 66.
Denatured type II 1.33 (1.01, 1.65) 1.16 (0.85, 1.4
GAGy 29.3 (27.0, 31.7) 35.7 (32.3, 39.
Pro MMP-2y 0.858 (0.671, 1.04) 0.769 (0.670, 0.
Activated MMP-2y 19.3 (16.1, 22.6) 11.6 (8.0, 15.2
ProMMP-9 1.50 (0.98, 2.02) 1.93 (1.5, 2.25
Hydroxylysiney 21.2 (20.1, 22.2) 22.6 (20.9, 24.
HL-Pyr 1.1 (1.0, 1.27) 1.03 (0.96, 1.1
L-Pyry 0.228 (0.203, 0.251) 0.200 (0.178, 0.
Total cross-links 1.92 (1.75, 2.08) 1.68 (1.57, 1.7
Subchondral bone
Collageny 13.4 (12.3, 14.6) 13.0 (12.49, 13
Ca:Py 2.73 (2.37, 3.09) 3.36 (2.97, 3.7
ALPy 1.10 (0.85, 1.35) 0.952 (0.873, 1.
Pro MMP-9y 3.07 (2.28, 3.86) 7.22 (2.14, 12.
Hydroxylysiney 14.9 (13.7, 16.1) 16.8 (14.1, 19.
HLKNLy 1.08 (0.959, 1.21) 0.976 (0.889, 1.
HL-Pyry 0.453 (0.391, 0.514) 0.425 (0.366, 0.
L-Pyry 0.097 (0.070, 0.124) 0.091 (0.075, 0.
Total cross-linksy 1.82 (1.64, 1.99) 1.67 (1.52, 1.8
Adjacent BMDy 519 (507, 530) 495 (479, 520
Mean (95% CI); #P< 0.05, ##P< 0.01, ###P< 0.001 comparing diet for DH; *P< 0.05, *P
y Those parameters for which the n-3 diet modiﬁed DH values towards those of the n
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(P¼ 0.0083), with toluidine blue (P¼ 0.059), cartilage structure
(P¼ 0.015) and OARSI criteria (P¼ 0.046) each being lower in the
n-3 (Fig. 1).
Pathogenic markers
Cartilage. The GAG content of the cartilage signiﬁcantly increased
(P¼ 0.003) with n-3 compared to the control diet in the DH strain
[Fig. 2(A)]. Levels of denatured type II collagen were reduced
slightly with the n-3 diet in both strains [Fig. 2(B)], although
comparison between strains showed no clear association with
pathology. High n-3 diet increased lysyl hydroxylation in the
OA-prone DH towards those seen in the non-prone control BS2
[P¼ 0.1, Fig. 3(A)], and this was reﬂected in signiﬁcantly decreased
levels of L-Pyr [P¼ 0.05, Fig. 3(B)]. The total level of cross-links was
also lower in the n-3 fed DH (P¼ 0.008, Table II). Levels of pro
MMP-9 were elevated, although not signiﬁcantly [Fig. 3(C)], whilst
total MMP-2 (NS) and the percentage active MMP-2 (P< 0.002)
levels were decreased [Fig. 3(D and E)] for the n-3 diet group.
Subchondral bone. The collagen biochemistry parameters measured
in the OA-prone strain all changed towards control BS2 levels as
a result of the n-3 diet. However, most of these failed to reach
signiﬁcance in this study (Table II). The Ca:P ratio increased in the DH
with the n-3 diet [P¼ 0.015, Fig. 4(C)].The BMD of the adjacent
proximal epiphyseal area also decreasedwith n-3 (P¼ 0.03, Table II).
MMP-9 expression increased [P¼ 0.07, Fig. 4(E)], and there was
a trend towards increased levels of collagen lysine hydroxylation
[P¼ 0.1, Fig. 4(A)], decreased HLKNL (P¼ 0.12) and decreased total
collagen cross-links (P¼ 0.17) with the n-3 diet (Table II).
Examining the overall data, of themeasures of cartilage and bone
pathogenicmarkers examined in the DH on a high n-3 or a standard
diet,16 changed in the direction of theOA-resistant BS2 as a result of
the n-3 diet (signiﬁcant in 7). Of the remainder, two (denatured type
II and total cross-links) showed no difference for breed, and two
(cartilage proMMP-9 and HL-Pyr) showed a non-signiﬁcant changeBS2
Standard diet n-3 diet
8)# 2.20 (0.05, 4.34)*** 1.78 (0.67, 4.24)
6) 59.2 (53.7, 64.8) 56.9 (46.4, 67.4)
8) 1.39 (1.11, 1.68) 1.23 (0.88, 1.58)
1)## 30.1 (27.4, 32.7) 30.3 (26.5, 34.1)
865) 0.289 (0.212, 0.366)*** 0.312 (0.245, 0.37)
)## 0 0
) 1.03 (0.85, 1.2)** 1.38 (1.08, 1.68)
3) 24.0 (22.0, 26.0)** 22.8 (21.0, 24.5)
) 1.28 (1.09, 1.46) 1.32 (1.26, 1.49)
221)# 0.103 (0.076, 0.131)*** 0.107 (0.070, 0.144)
8)## 2.05 (1.84, 2.26) 2.13 (1.96, 2.30)
.48) 11.7 (10.4, 13.1)* 12.7 (11.6, 13.7)
5)# 4.39 (3.43, 5.35)** 4.95 (4.11, 5.79)
03) 0.779 (0.58, 0.98)* 0.800 (0.600, 1.00)
3) 9.83 (5.65, 14.01)*** 12.4 (8.86, 15.9)
4) 16.1 (14.7, 17.6) 16.9 (14.6, 19.2)
06) 0.927 (0.831, 1.02)* 0.955 (0.840, 1.07)
484) 0.356 (0.312, 0.4)** 0.393 (0.361, 0.425)
107) 0.086 (0.065, 0.106) 0.087 (0.058, 0.117)
2) 1.52 (1.40, 1.64)** 1.63 (1.52, 1.75)
)# 465 (448, 483)*** 461.1 (440, 482)
< 0.01, ***P< 0.001 comparing strain (n-6 diet).
on-OA strain.
Fig. 4. Differences in biochemical parameters of subchondral bone as a result of Strain
(DH vs BS2) or Diet (standard diet black bars, n-3 diet grey bars, BS2/n-3 unﬁlled grey
bars). (A) Lysyl hydroxylation of collagen (DH std n¼ 10, DH n-3 n¼ 10, BS2 std n¼ 10,
BS2 n-3 n¼ 8); (B) Total collagen cross-links: (C) Ca:PO4 ratio (n¼ 10); (D) Alkaline
phosphatise (DH std n¼ 10, DH n-3 n¼ 10, BS2 std n¼ 8, BS2 n-3 n¼ 10); (E) Pro
MMP-9 (DH std n¼ 10, DH n-3 n¼ 10, BS2 std n¼ 8, BS2 n-3 n¼ 8). For diet #P< 0.05.
For strain *P< 0.05, **P< 0.01, ***P< 0.001.
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tary changes with respect to the model, a binomial discrete proba-
bility distribution demonstrated a probability of P¼ 0.0046 that
these occurred by chance, and Chi-square test showed a probability
of P¼ 0.001 that the data distribution was equal.
Effect of n-3 in promoting OA in control BS2 strain
The n-3 diet had little apparent effect on control BS2 animals in
histopathological OA scores, and fewer effects, compared with DH,
on biochemical parameters investigated in this study. This is in line
with n-3 modulating both disease parameters in OA and baseline
physiological levels of bone and cartilage mediators. The only
signiﬁcant change with the high n-3 diet in the BS2 was raised
levels of pro MMP-9 in cartilage [P¼ 0.033, Fig. 3(C)].
Discussion
The principle outcomes from this study were (1) that n-3 PUFAs
reduce OA pathology in this naturally occurring model, and (2) that
a number of physiological markers of disease conﬁrmed this at
a mechanistic level. Also, there was no evidence that n-3 contrib-
uted to an increase in OA in either strain. Furthermore, we were
able to conﬁrm the utility of this model of OA and demonstrated
a number of changes in metabolism and composition not previ-
ously reported which may give further insight into the model, and
into early OA changes in human disease.
Characterisation of the DH/BS2 model
The pathology scores show clear and spontaneous development
of OA in the DH guinea pigs, with little apparent pathology in theBS2 strain at 30 weeks. Characterisation of this model of sponta-
neous OA, with BS2 as a non-disease prone control, provides
valuable information on changes in composition andmetabolism of
the cartilage and subchondral bone in early OA. However, it should
be acknowledged that OA does develop in much older BS2 guinea
pigs, and this strainmaymore accurately be described as late onset.
This is the ﬁrst study to report levels of collagen cross-linking in
guinea pig joints. Cartilage collagen of the DH animals was found to
have a reduced lysyl hydroxylation compared with control BS2s,
which was reﬂected in higher levels of the less hydroxylated mature
collagen cross-link, L-Pyr. Pokharna et al reported no difference in
overall Pyr levels (L-Pyr plus HL-Pyr) in a rabbit model of OA, in
accordance with our ﬁndings36. However, Bank et al reported
elevated levels of hydroxylysine and HL-Pyr in degenerated human
articular cartilage37. However, these changes were associated with
individuals with no apparent OA, unlike the present study.
We identiﬁed higher levels of both pro MMP-9 and pro MMP-2
in the DH cartilage compared with BS2, and that active MMP-2 was
only detected in OA DH cartilage, in accordance with studies in
other species38. Elevated catabolism/metabolism, as shown by
increased levels and activation of MMPs is associated with OA
progression39e41. MMP-9 is linked with inﬂammation, and MMP-2
with collagen turnover. As both are degradative proteases, their
association with OA may be expected. However, as both have a role
in tissue repair their relationship with OA is likely to be complex.
In subchondral bone, we identiﬁed elevated levels of ALP in DH
compared with BS2, consistent with previous studies of OA in-
vitro42,43 and in-vivo24,44,45, demonstrating increased subchondral
bone metabolism in guinea pig OA. Pro and active MMP-2 were
barely detectable in DH bone, and absent in the control BS2 strain.
Previous studies reported elevatedMMP-2 and enhanced activation
in OA bone, most notably in the proximal epiphysis46. However
MMP-9 was found to be lower in the OA-developing DH strain than
the control strain. MMP-9 is produced by osteoclasts, and is
elevated during active bone resorption47,48. Reduced MMP-9 in the
OA-developing strain is in line with subchondral bone sclerosis in
OA49, and corroborates the higher levels of bone formation (ALP)
seen in DH. However, other studies have shown a link between OA
and raised MMP-9. This contradiction may relate to their bone
sampling site being outside the subchondral compartment41, or
disease being more advanced47.
Therewere elevated levels of individual and total collagen cross-
links in the DH subchondral bone compared with the control strain.
There have been no other reports to the author’s knowledge of
collagen cross-linking in the subchondral bone in any species,
although some have analysed trabecular bone immediately prox-
imal to the subchondral plate46. Raised levels of cross-links are
indicative of a stiffer subchondral bone, in line with the previous
ﬁndings indicating sclerosis in the OA-developing strain23.
Guinea pig subchondral bone has an unusually high Ca:P ratio
(mean 3.86). Although this has not been reported before in guinea
pigs, in other species this is generally between 1.7 and 2, increasing
with maturity of hydroxyapatite. High Ca:P ratios have been
reported in OA subchondral bone50,51 but in this study it was the
control BS2 strain which exhibited the highest ratios. High Ca:P
ratios could be indicative of the presence of amorphous, calcium
rich deposits52, and matrix vesicles associated with cartilage min-
eralisation accumulating large amounts of calcium53,54. The low
Ca:P in the OA-prone DH strain may result from formation of new,
less mature bone, in line with raised ALP.
Effect of n-3 on disease progression in OA-developing DH strain
Few experimental studies have investigated the effects of n-3
PUFAs on OA, although there is clinical evidence that increasing
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management in humans11 and other species9. Not all studies
however conclude that dietary n-3 PUFA supplementation is of
beneﬁt, in the treatment of OA55. It is possible that OA could be
aggravated due to the potential for increased bone formationwhich
is linked to the progression of OA. This study is the ﬁrst to look at
both cartilage and subchondral bone changes with increased die-
tary n-3 PUFAs.
In terms of gross pathology, the high n-3 diet signiﬁcantly and
substantially (by 50%) reduced OA associated changes in the DH
strain, with no signiﬁcant effect on the control strain. Having
established this improvement in OA pathology, we went on to
demonstrate parallel changes in a number of compositional and
metabolic markers of cartilage and bone function.
Increased cartilage GAG content, reduced denatured type II
collagen (NS), and reduced pro and activated MMP-2 in DH guinea
pigs fed an n-3 diet are all indicative of disease attenuation. Others,
such as L-Pyr and lysine hydroxylation change to be more in line
with the control animals. Only cartilage MMP-9 changed in the
opposite direction to that seen in the control animals, though not
signiﬁcantly. However, as noted, the relationship between MMP-9,
cartilage degradation and regeneration is likely to be complex.
Omega-3 supplemented DH guinea pigs had fewer calcifying
cartilage lesions identiﬁed as part of the Mankin grading, corrob-
orated by reduction in markers of mineralisation, collagen lysyl
hydroxylation and L-Pyr cross-links, each shifting towards those
seen in the BS2s. Taken together, the analyses of the biochemical
parameters demonstrate an n-3 treatment effect, and provide
evidence of particular mechanisms of disease, but that these should
be explored further to conﬁrm links to n-3 diet.
Evidence that n-3 modiﬁes some elements only in the disease-
prone animals, whilst others are also moderated in the control
strain, supports the contention that n-3 regulates both the disease
process and the underlying physiology of cartilage and subchondral
bone in the absence of overt disease. As there is evidence of OA in
very old BS2 guinea pigs, it could be speculated that those elements
modiﬁed in the “later onset” BS2 as well as the DH represent the
earliest stages of OA pathology, such that denatured type II
collagen, collagen hydroxylation (in cartilage and bone), MMP-9
(also in both) and Ca:P, are early events, whereas changes in GAG
content, collagen crosslinking, MMP-2 and ALP are part of estab-
lished disease in th DH animals. Thus n-3 has the potential to
prevent or delay the onset of disease as well as to reduce its
progression.
Though no previous in vivo studies have examined cartilage
matrix changes with n-3, in vitro studies using bovine chondrocytes
identiﬁed reduced expression for cartilage-degrading proteinases,
cyclooxygenase-2 and inﬂammatory cytokines in the presence of n-
3, in particular eicosapentanoic acid12.
Reports on the effect of PUFAs on bone are more numerous, with
n-3 PUFAs generally reducing bone loss, by decreasing bone
resorption56, and/or increasing bone formation57,58. However
speciﬁc effects on subchondral bone are less well documented, and
extrapolation of data from other skeletal sites may bemisleading as
sclerotic subchondral bone present in OA is dissimilar to other bone
sites and disease states17,23,49,59. Increase in subchondral bone
formation as a result of n-3 is potentially detrimental in the
progression of OA. However, in the OA-prone DH guinea pigs, n-3
acts to modify markers indicating reduced subchondral bone
deposition, including increased pro MMP-9, increased Ca:P ratio,
decreased collagen content and decreased ALP levels. Supplemen-
tation with n-3 also directed collagen cross-linking and lysine
hydroxylation towards control BS2 levels in DH subchondral bone.
Supplementation with n-3 reduced the BMD of the adjacent
proximal epiphyseal bone, again towards control levels. This iscontrary to expectations as n-3 is generally reported to increase
bone density14, but as increased density of bone underlying carti-
lage is thought to contribute to OA19, this may demonstrate
a further protective effect of n-3.
There is circumstantial evidence for a link between human OA
and a high n-6:n-3 ratio. High n-6, particularly arachidonic acid,
have been reported in bone from OA patients2, and an association
between OA and subchondral osteoblastic production of PGE2, IL-6,
and COX-2 levels has been identiﬁed, as well as an elevated
response to exogenous PGE260.
Therefore supplementation of n-3 PUFAs returns the balance in
n-3 and n-6 to a more ‘normal’ functional state, reducing signs of
OA in both cartilage and subchondral bone.
Effect of n-3 on OA promotion in control BS2 strain
There is little evidence from this study for any detrimental
effects of n-3 supplementation in the control OA-resistant strain.
This suggests that there are no ill effects of n-3 on OA development
in disease free individuals.
Limitations of the study
The principle limitations of this study were the small quantities
of tissues available for analysis and the large number of analyses
attempted, such that many measures were at the lower end of their
detectable range. A group size of 10 was adequate for determining
differences in pathology with diet, which was the primary outcome
of this study and for detecting differences in strain. However, there
were a number of biochemical measures that did not reach
signiﬁcance when comparing diets within the OA-developing
strain. It should also be noted that the development of OA in this
model is at an early age by comparison with human disease, and
occurs on an accelerated timescale.
Conclusion
This study demonstrates clear beneﬁts of n-3 supplementation
in reducing the signs of OA in a naturally occurring model of
disease. Furthermore, there was no sign that increased n-3 would
lead to disease in the OA free strain. We have also further charac-
terised this model, and identiﬁed fundamental differences in
cartilage and bone biology associated with OA. We propose that
a high n-3 diet has the potential to reduce signs of OA in both
cartilage and subchondral bone. Further studies are needed to
determine the inﬂuence of n-3 on established disease, and to
conﬁrm these effects in human OA.
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